PERSISTENCE ON GOLIMUMAB AS SECOND LINE BIOLOGICAL THERAPY IN PATIENTS WITH SPONDYLOARTHRITIS (AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS). GO-BEYOND, A RETROSPECTIVE STUDY

Simple item page
dc.conference.dateJUN 13-16, 2018
dc.conference.titleCongress of the European-League-Against-Rheumatism (EULAR)
dc.contributor.authorGonzalez Fernandez, C. M.
dc.contributor.authorAlegre-Sancho, J. J.
dc.contributor.authorGarcia-Carazo, S.
dc.contributor.authorRodriguez-Heredia, J. M.
dc.contributor.authorBachiller-Corral, J.
dc.contributor.authorMartin Lopez, M.
dc.contributor.authorRetuerto Guerrero, M.
dc.contributor.authorMartin Santos, J. M.
dc.contributor.authorAlvarez-Rivas, N.
dc.contributor.authorEgues Dubuc, C. A.
dc.contributor.authorVilla-Blanco, I.
dc.contributor.authorLaiz, A.
dc.contributor.authorTovar Beltran, J. V.
dc.contributor.authorBeltran, E.
dc.contributor.authorRaya, E.
dc.contributor.authorIbanez Bosch, R.
dc.contributor.authorManero, J.
dc.contributor.authorPons Dolset, J.
dc.contributor.authorGarcia Magallon, B.
dc.contributor.authorArteaga, M. J.
dc.contributor.authorCea-Calvo, L.
dc.contributor.authorJuanola Roura, X.
dc.contributor.authoraffiliation[Gonzalez Fernandez, C. M.] Hosp Univ Gregorio Maranon, Dept Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Alegre-Sancho, J. J.] Hosp Univ Doctor Peset, Rheumatol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Garcia-Carazo, S.] Hosp Univ La Paz, Rheumatol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Rodriguez-Heredia, J. M.] Hosp Univ Getafe, Rheumatol Dept, Getafe, Spain
dc.contributor.authoraffiliation[Bachiller-Corral, J.] Hosp Univ Ramon & Cajal, Rheumatol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Martin Lopez, M.] Hosp Univ Doce Octubre, Rheumatol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Retuerto Guerrero, M.] Hosp Univ Leon, Rheumatol Dept, Leon, Spain
dc.contributor.authoraffiliation[Martin Santos, J. M.] Hosp Univ Rio Hortega, Rheumatol Dept, Valladolid, Spain
dc.contributor.authoraffiliation[Alvarez-Rivas, N.] Hosp Univ Lucus Augusti, Rheumatol Dept, Lugo, Spain
dc.contributor.authoraffiliation[Egues Dubuc, C. A.] Hosp Univ Donostia, Rheumatol Dept, Donostia San Sebastian, Spain
dc.contributor.authoraffiliation[Villa-Blanco, I.] Hosp Sierrallana, Dept Rheumatol, Torrelavega, Cantabria, Spain
dc.contributor.authoraffiliation[Laiz, A.] Hosp Santa Creu & Sant Pau, Rheumatol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Tovar Beltran, J. V.] Hosp Gen Univ Elche, Rheumatol Dept, Elche, Spain
dc.contributor.authoraffiliation[Beltran, E.] Parc Salut Mar, Rheumatol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Raya, E.] Hosp Univ San Cecilio, Rheumatol Dept, Granada, Spain
dc.contributor.authoraffiliation[Ibanez Bosch, R.] Complejo Hosp Navarra, Rheumatol Dept, Pamplona, Spain
dc.contributor.authoraffiliation[Manero, J.] Hosp Univ Miguel Servet, Rheumatol Dept, Zaragoza, Spain
dc.contributor.authoraffiliation[Pons Dolset, J.] Hosp Royo Villanova, Rheumatol Dept, Zaragoza, Spain
dc.contributor.authoraffiliation[Garcia Magallon, B.] Hosp Gen San Jorge, Rheumatol Dept, Huesca, Spain
dc.contributor.authoraffiliation[Arteaga, M. J.] Merck Sharp & Dohme Ltd, Med Affairs, Madrid, Spain
dc.contributor.authoraffiliation[Cea-Calvo, L.] Merck Sharp & Dohme Ltd, Med Affairs, Madrid, Spain
dc.contributor.authoraffiliation[Juanola Roura, X.] Hosp Univ Bellvitge, Dept Rheumatol, Lhospitalet De Llobregat, Spain
dc.contributor.funderMerck Sharp and Dohme, Spain
dc.date.accessioned2025-01-07T14:00:33Z
dc.date.available2025-01-07T14:00:33Z
dc.date.issued2018-06-01
dc.identifier.doi10.1136/annrheumdis-2018-eular.2164
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/77/Suppl_2/1543.1.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/26047
dc.identifier.wosID444351004411
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario San Cecilio
dc.page.number1543-1543
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titlePERSISTENCE ON GOLIMUMAB AS SECOND LINE BIOLOGICAL THERAPY IN PATIENTS WITH SPONDYLOARTHRITIS (AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS). GO-BEYOND, A RETROSPECTIVE STUDY
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number77
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario San Cecilio

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía